
CAS 956014-19-0
:Formula:C16H9BrF6N6S
InChI:InChI=1S/C16H9BrF6N6S/c17-9-1-2-12(11(6-9)13-26-28-29-27-13)25-14(30)24-10-4-7(15(18,19)20)3-8(5-10)16(21,22)23/h1-6H,(H2,24,25,30)(H,26,27,28,29)
InChI key:MDKAFDIKYQMOMF-UHFFFAOYSA-N
SMILES:C1=CC(=C(C=C1Br)C2=NNN=N2)NC(=S)NC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
1-(3,5-Bis(Trifluoromethyl)Phenyl)-3-(4-Bromo-2-(2H-Tetrazol-5-Yl)Phenyl)Thiourea
CAS:1-(3,5-Bis(Trifluoromethyl)Phenyl)-3-(4-Bromo-2-(2H-Tetrazol-5-Yl)Phenyl)ThioureaFormula:C16H9BrF6N6SPurity:95%Molecular weight:511.24Thiourea, N'-[3,5-bis(trifluoromethyl)phenyl]-N-[4-bromo-2-(2H-tetrazol-5-yl)phenyl]-
CAS:Formula:C16H9BrF6N6SPurity:95%Color and Shape:SolidMolecular weight:511.2423NS 11021
CAS:NS 11021 (NS11021) , a novel opener of large-conductance Ca(2+)-activated K(+) channelsFormula:C16H9BrF6N6SPurity:97.26%Color and Shape:SolidMolecular weight:511.241-(3,5-Bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(2H-tetrazol-5-yl)phenyl)thiourea
CAS:1-(3,5-Bis(trifluoromethyl)phenyl)-3-(4-bromo-2-(2H-tetrazol-5-yl)phenyl)thioureaFormula:C16H9BrF6N6SPurity:95%Molecular weight:511.24NS 11021
CAS:NS 11021 is a drug that inhibits the mitochondrial membrane potential, which is the driving force for ATP synthesis. It can be used to treat bowel disease and cardiac diseases such as hypertrophic cardiomyopathy. NS 11021 also has a pharmacological effect on channels that open in response to an increase in cytosolic calcium levels. This includes atrial and activated potassium channels, which are important for the propagation of action potentials in the heart. NS 11021 can also be used to treat experimental models of ischemia–reperfusion injury due to its ability to inhibit energy metabolism.
Formula:C16H9BrF6N6SPurity:Min. 95%Molecular weight:511.24 g/mol





